MUVROC Trademark

Trademark Overview


On Friday, November 21, 2014, a trademark application was filed for MUVROC with the United States Patent and Trademark Office. The USPTO has given the MUVROC trademark a serial number of 86461283. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, November 13, 2015. This trademark is owned by Glaxo Group Limited. The MUVROC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardio...
muvroc

General Information


Serial Number86461283
Word MarkMUVROC
Filing DateFriday, November 21, 2014
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, November 13, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "MUVROC" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 29, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, November 13, 2015ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, November 13, 2015ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 17, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 17, 2015NON-FINAL ACTION E-MAILED
Friday, April 17, 2015NON-FINAL ACTION WRITTEN
Tuesday, March 31, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 31, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 31, 2015ASSIGNED TO LIE
Tuesday, March 24, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, March 11, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 11, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, March 11, 2015SUSPENSION LETTER WRITTEN
Tuesday, March 10, 2015ASSIGNED TO EXAMINER
Saturday, November 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 25, 2014NEW APPLICATION ENTERED IN TRAM